|
|
Line 130: |
Line 130: |
| ====Hormonotherapy==== | | ====Hormonotherapy==== |
| *[[Hydrocortisone (Cortef)]] | | *[[Hydrocortisone (Cortef)]] |
| + | |
| + | ==Pixantrone & Rituximab== |
| + | {| class="wikitable" style="float:right; margin-left: 5px;" |
| + | |- |
| + | |[[#top|back to top]] |
| + | |} |
| + | ===Regimen=== |
| + | ====Chemotherapy==== |
| + | *[[Pixantrone (Pixuvri)]] |
| + | ====Targeted therapy==== |
| + | *[[Rituximab (Rituxan)]] |
| | | |
| ==TG+Bev== | | ==TG+Bev== |
Revision as of 18:48, 9 August 2020
Regimens that have not proven to be superior to a standard-of-care comparison and are thus unlikely to be expanded upon unless new evidence comes forward. This page is primarily to drive the Ontology.
Abiraterone & Enzalutamide
Regimen
Hormonotherapy
Bortezomib & Bevacizumab
Regimen
Targeted therapy
Bortezomib & Siltuximab
Regimen
Targeted therapy
CE & Ipilimumab
CE & Ipilimumab: Carboplatin, Etoposide, Ipilimumab
Regimen
Chemotherapy
Immunotherapy
CE & Thalidomide
CE & Thalidomide: Carboplatin, Etoposide, Thalidomide
Regimen
Chemotherapy
Targeted therapy
EP & Ipilimumab
EP & Ipilimumab: Etoposide, Platinol (Cisplatin), Ipilimumab
Regimen
Chemotherapy
Immunotherapy
EP, Tamoxifen, RT
EP, GM-CSF, RT: Etoposide, Platinol (Cisplatin), Tamoxifen, Radiation Therapy
Regimen
Chemotherapy
Hormonotherapy
Radiotherapy
FULV & Trimetrexate
FULV & Trimetrexate: 5-FU & LeucoVorin (Folinic acid), Trimetrexate
Regimen
Chemotherapy
Ixabepilone & Bevacizumab
Regimen
Chemotherapy
Targeted therapy
MFL
MFL: Methyl-lomustine (MeCCNU), 5-FU & LeucoVorin (Folinic acid)
Regimen
Chemotherapy
Mitoxantrone & Hydrocortisone
Regimen
Chemotherapy
Hormonotherapy
Pixantrone & Rituximab
Regimen
Chemotherapy
Targeted therapy
TG+Bev
TG+Bev: Taxotere (Docetaxel), Gemcitabine, Bevacizumab
Regimen
Chemotherapy
Targeted therapy
TX+Bev
TX+Bev: Taxotere (Docetaxel), Xeloda (Capecitabine), Bevacizumab
Regimen
Chemotherapy
Targeted therapy
Vinorelbine & Hydrocortisone
Regimen
Chemotherapy
Hormonotherapy